Terms: = Breast cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Prognosis
54 results:
1. Methylation-Mediated Silencing of ATF3 Promotes Thyroid cancer Progression by Regulating Prognostic Genes in the MAPK and PI3K/AKT Pathways.
Xiao X; Chen M; Sang Y; Xue J; Jiang K; Chen Y; Zhang L; Yu S; Lv W; Li Y; Liu R; Xiao H
Thyroid; 2023 Dec; 33(12):1441-1454. PubMed ID: 37742107
[No Abstract] [Full Text] [Related]
2. Computational reactive-diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib.
Schettini F; De Bonis MV; Strina C; Milani M; Ziglioli N; Aguggini S; Ciliberto I; Azzini C; Barbieri G; Cervoni V; Cappelletti MR; Ferrero G; Ungari M; Locci M; Paris I; Scambia G; Ruocco G; Generali D
Sci Rep; 2023 Jul; 13(1):11951. PubMed ID: 37488154
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of different cyclin-dependent kinase inhibitors and KI-67 levels on survival and toxicity in breast cancer treatment.
Bayram E; Selvi O; Köşeci T; Mete B; Yaslıkaya Ş; Paydaş S
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(11):5230-5239. PubMed ID: 37318497
[TBL] [Abstract] [Full Text] [Related]
4. c-Myc-Targeting PROTAC Based on a TNA-DNA Bivalent Binder for Combination Therapy of Triple-Negative breast cancer.
Li X; Zhang Z; Gao F; Ma Y; Wei D; Lu Z; Chen S; Wang M; Wang Y; Xu K; Wang R; Xu F; Chen JY; Zhu C; Li Z; Yu H; Guan X
J Am Chem Soc; 2023 Apr; 145(16):9334-9342. PubMed ID: 37068218
[TBL] [Abstract] [Full Text] [Related]
5. MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: max Interaction and Tumor Growth in a MYC-Dependent Manner.
Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson LG
Cancer Res Commun; 2022 Mar; 2(3):182-201. PubMed ID: 36874405
[TBL] [Abstract] [Full Text] [Related]
6.
Gonullu B; Angeli E; Pamoukdjian F; Bousquet G
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834998
[TBL] [Abstract] [Full Text] [Related]
7. Multi-candidate immunohistochemical markers to assess radiation response and prognosis in prostate cancer: results from the CHHiP trial of radiotherapy fractionation.
Wilkins A; Gusterson B; Tovey H; Griffin C; Stuttle C; Daley F; Corbishley CM; Dearnaley D; Hall E; Somaiah N
EBioMedicine; 2023 Feb; 88():104436. PubMed ID: 36708693
[TBL] [Abstract] [Full Text] [Related]
8. Discovery of potent and selective HER2 PROTAC degrader based Tucatinib with improved efficacy against HER2 positive cancers.
Hu M; Li Y; Li J; Zhou H; Liu C; Liu Z; Gong Y; Ying B; Xie Y
Eur J Med Chem; 2022 Dec; 244():114775. PubMed ID: 36208507
[TBL] [Abstract] [Full Text] [Related]
9. First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic cancers Using
Loft M; Christensen C; Clausen MM; Carlsen EA; Hansen CP; Kroman N; Langer SW; Høgdall C; Madsen J; Gillings N; Nielsen CH; Klausen TL; Holm S; Loft A; Berthelsen AK; Kjaer A
J Nucl Med; 2022 Dec; 63(12):1871-1879. PubMed ID: 35589407
[TBL] [Abstract] [Full Text] [Related]
10. [Pretreatment evaluation of
Peng P; Wu N; Tao XL; Liu Y; Lyu L; Cheng X
Zhonghua Zhong Liu Za Zhi; 2022 Apr; 44(4):370-376. PubMed ID: 35448927
[No Abstract] [Full Text] [Related]
11. Established Serum Biomarkers Are Prognostic Factors in Patients With Oligometastatic cancer and Brain Involvement.
Nieder C; Dalhaug A; Mannsåker B
In Vivo; 2022; 36(2):801-805. PubMed ID: 35241535
[TBL] [Abstract] [Full Text] [Related]
12. NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.
Jiménez-Sánchez D; Ariz M; Chang H; Matias-Guiu X; de Andrea CE; Ortiz-de-Solórzano C
Med Image Anal; 2022 May; 78():102384. PubMed ID: 35217454
[TBL] [Abstract] [Full Text] [Related]
13. A New Prognostic Index in Young breast cancer Patients.
Demir H; Demirci A; Eren SK; Beypinar I; Davarcı SE; Baykara M
J Coll Physicians Surg Pak; 2022 Jan; 32(1):86-91. PubMed ID: 34983154
[TBL] [Abstract] [Full Text] [Related]
14. Automated breast volume scanning combined with shear wave elastography for diagnosis of triple-negative breast cancer and human epidermal growth factor receptor 2-positive breast cancer.
Chen W; Ru R; Wang F; Li M
Rev Assoc Med Bras (1992); 2021 Aug; 67(8):1167-1171. PubMed ID: 34669864
[TBL] [Abstract] [Full Text] [Related]
15. Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark.
Hjorth CF; Damkier P; Ejlertsen B; Lash T; Sørensen HT; Cronin-Fenton D
BMC Med; 2021 Sep; 19(1):235. PubMed ID: 34587961
[TBL] [Abstract] [Full Text] [Related]
16. Benefit of adjuvant chemotherapy in patients with special histology subtypes of triple-negative breast cancer: a systematic review.
Trapani D; Giugliano F; Uliano J; Zia VAA; Marra A; Viale G; Ferraro E; Esposito A; Criscitiello C; D'amico P; Curigliano G
Breast Cancer Res Treat; 2021 Jun; 187(2):323-337. PubMed ID: 34043122
[TBL] [Abstract] [Full Text] [Related]
17. Elevated Postoperative Levels of Serum C-reactive Protein Are Associated With Shorter Long-term Survival After Resection of Colorectal Liver Metastases, Regardless of the Occurrence of Infectious Complications.
Shibutani M; Kimura K; Kashiwagi S; Wang EN; Okazaki Y; Maeda K; Hirakawa K; Ohira M
Anticancer Res; 2021 May; 41(5):2605-2610. PubMed ID: 33952490
[TBL] [Abstract] [Full Text] [Related]
18. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
[TBL] [Abstract] [Full Text] [Related]
19. FDG uptake reflects breast cancer immunological features: the PD-L1 expression and degree of TILs in primary breast cancer.
Hirakata T; Fujii T; Kurozumi S; Katayama A; Honda C; Yanai K; Tokuda S; Nakazawa Y; Obayashi S; Yajima R; Kaira K; Oyama T; Shirabe K
Breast Cancer Res Treat; 2020 Jun; 181(2):331-338. PubMed ID: 32253685
[TBL] [Abstract] [Full Text] [Related]
20. Lung recurrence and its therapeutic strategy in patients with pancreatic cancer.
Kurahara H; Maemura K; Mataki Y; Tanoue K; Iino S; Kawasaki Y; Idichi T; Arigami T; Mori S; Shinden Y; Higashi M; Ueno S; Shinchi H; Natsugoe S
Pancreatology; 2020 Jan; 20(1):89-94. PubMed ID: 31787525
[TBL] [Abstract] [Full Text] [Related]
[Next]
